
Alignment Healthcare (ALHC) Stock Forecast & Price Target
Alignment Healthcare (ALHC) Analyst Ratings
Bulls say
Alignment Healthcare Inc is positioned to capitalize on the favorable 2026 rate update, particularly as many managed care organizations are reducing benefits, while Alignment maintains a competitive advantage due to its Stars funding. The company’s integrated Medicare Advantage-Value-Based Care model is expected to support long-term market share gains and above-average growth rates, enhancing its financial stability. Moreover, the anticipated gross profit per member per month (PMPM) is likely to increase significantly, progressing from the $90-$150 range in the first two years to over $230 PMPM in years three to five, which further solidifies the positive outlook for Alignment Healthcare's stock.
Bears say
Alignment Healthcare Inc faces several challenges that contribute to a negative outlook on its stock. Despite showcasing a lower average daily cost (ADK) during a period of heightened healthcare utilization, the company struggles with data friction among various payors and inconsistency in results from employed or affiliated primary care providers (PCPs), which could hinder overall performance. Furthermore, while the valuation multiple is positioned slightly above the long-term range for peer managed care organizations (MCOs), the reliance on a technology platform and clinical model may not sufficiently mitigate these operational drawbacks, raising concerns over future earnings stability and growth potential.
This aggregate rating is based on analysts' research of Alignment Healthcare and is not a guaranteed prediction by Public.com or investment advice.
Alignment Healthcare (ALHC) Analyst Forecast & Price Prediction
Start investing in Alignment Healthcare (ALHC)
Order type
Buy in
Order amount
Est. shares
0 shares